AI Summary

The Prima system, approved in Europe in July and pending FDA clearance in the United States, uses a retinal implant paired with camera‑equipped eyeglasses to restore vision for people with advanced age‑related macular degeneration. Developed by California‑based Science Corporation, the implant mimics lost photoreceptor cells and sends visual information directly to remaining retinal circuitry and the brain. After training sessions, more than 80 % of recipients were able to read, complete crosswords and use their phones. Ophthalmologist Frank Brodie of UCSF, the medical director for Prima, said the device leverages the body’s natural processing functions.

AI summaries can be wrong sometimes—always verify important details using the source article.